NOTCH1 inhibition enhances immunogenicity and sensitizes triple-negative breast cancer to immune checkpoint inhibitors
Abstract Although immune checkpoint inhibitors (ICIs) have elicited desirable clinical outcomes, their effective application remains an obstacle due to immunologically “cold” tumors that manifest lymphocyte exhaustion or poor infiltration. Hence, exploring new therapeutic strategies to enhance antit...
Saved in:
| Main Authors: | Ying Gao, Lin Zuo, Yu Zheng, Keyan Sun, Yunhui Gao, Xiaobo Xu, Zengqiang Li, Daiying Zuo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Breast Cancer Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13058-025-02045-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Notch and Hedgehog Signalling Axis Drive Senescence in HER2-Positive Breast Cancer Resistant to Trastuzumab
by: Asiye Büşra Boz Er, et al.
Published: (2024-12-01) -
Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors
by: Lucillia Bezu, et al.
Published: (2023-12-01) -
The Reduced Immunogenicity of Zoster Vaccines in CMV-Seropositive Older Adults Correlates with T Cell Imprinting
by: Adriana Weinberg, et al.
Published: (2025-03-01) -
Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway
by: Changhao Wu, et al.
Published: (2025-05-01) -
Construction of a prognostic model and identification of key genes in liver hepatocellular carcinoma based on multi-omics data
by: Kun Tang, et al.
Published: (2025-04-01)